IL-1 beta Antikörper (Magnetic Particles)
Kurzübersicht für IL-1 beta Antikörper (Magnetic Particles) (ABIN1690225)
Target
Alle IL-1 beta (IL1B) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
anti-Interleukin 1, beta (IL1B) (AA 101-200) antibody
IL1B Reaktivität: Human, Maus, Ratte, Kaninchen, Schwein, Rind (Kuh) WB, ELISA, FACS, IF (p), IHC (p), IF (cc), IHC (fro), DB Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 1, beta (IL1B) antibodyIL1B Reaktivität: Human IHC, ELISA, ICC Wirt: Maus Monoclonal 3A6 unconjugated
anti-Interleukin 1, beta (IL1B) (AA 170-269) antibodyIL1B Reaktivität: Human WB, ELISA, IP, IF Wirt: Maus Monoclonal 2A8 unconjugated
anti-Interleukin 1, beta (IL1B) (AA 161-269) antibodyIL1B Reaktivität: Human, Maus, Ratte, Kaninchen, Rind (Kuh) WB, ELISA, IF (p), IHC (p), IF (cc), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 1, beta (IL1B) (AA 117-269) antibodyIL1B Reaktivität: Human ELISA, ICC, FACS Wirt: Maus Monoclonal 5C3B7 unconjugated
anti-Interleukin 1, beta (IL1B) (AA 117-269) antibodyIL1B Reaktivität: Human IHC, ELISA, ICC, FACS Wirt: Maus Monoclonal 6F12D5 unconjugated
anti-Interleukin 1, beta (IL1B) (AA 148-174) antibodyIL1B Reaktivität: Human, Maus WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB21917 unconjugated
anti-Interleukin 1, beta (IL1B) (AA 1-269) antibodyIL1B Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 1, beta (IL1B) (AA 1-266) antibodyIL1B Reaktivität: Schaf WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 1, beta (IL1B) (AA 1-269) antibodyIL1B Reaktivität: Human WB, PLA Wirt: Kaninchen Polyclonal unconjugated
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- 4 °C
-
-
- IL-1 beta (IL1B) (Interleukin 1, beta (IL1B))
-
Andere Bezeichnung
- IL-1 beta
-
Pathways
- NF-kappaB Signalweg, Interferon-gamma Pathway, TLR Signalweg, Negative Regulation of Hormone Secretion, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Glycosaminoglycan Metabolic Process, Myometrial Relaxation and Contraction, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Autophagie, Cancer Immune Checkpoints, Inflammasome
Target
-
